Trial Profile
Safety and efficacy of tipiracil/trifluridine in patients with metastatic colorectal cancer: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Apr 2016
Price :
$35
*
At a glance
- Drugs Tipiracil/trifluridine (Primary) ; Regorafenib
- Indications Adenocarcinoma; Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Apr 2016 New trial record
- 01 Apr 2016 Results published in the Anticancer Research